Gene · 10468
Papers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,272
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Head Color Morph- and Sex-Specific Differences in Follistatin Gene Expression in the Gouldian Finch Brain. | J Comp Neurol | 2025 | 41108203 | PubTator, text mining | PubMed |
| FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancer. | J Exp Clin Cancer Res | 2025 | 41029436 | PubTator, text mining | PubMed |
| Musculoskeletal Complications in COVID-19: Exploring the Role of Key Biomarkers. | Int J Mol Sci | 2025 | 40943488 | PubTator, text mining | PubMed |
| Relationship Between High Serum Levels of Follistatin with Impaired Physical Function, and Severe Disease Activity in Rheumatoid Arthritis. | Int J Mol Sci | 2025 | 40943156 | PubTator, text mining | PubMed |
| Pancreatic Cancer and Benign Pancreatic Cystic Lesions: Differences in Cytokines, Growth Factors, and Immunological Markers Concentrations in Serum and Cystic Fluid. | Cancers (Basel) | 2025 | 40940878 | PubTator, text mining | PubMed |
| Hyperandrogenism in polycystic ovary syndrome augments Estrogen synthesis through AR-FOXL2-mediated activation of the aromatase gene in granulosa cells. | J Ovarian Res | 2025 | 40898340 | PubTator, text mining | PubMed |
| Activin A/Follistatin Axis in Airway Diseases and its Association With Recurrent Exacerbations. | In Vivo | 2025 | 40877175 | PubTator, text mining | PubMed |
| Inhibition of Activin A Signaling by Follistatin Alleviates Diabetic Kidney Disease Burden. | Kidney360 | 2025 | 40875507 | PubTator, text mining | PubMed |
| The Influence of Irisin on Selected Organs-The Liver, Kidneys, and Lungs: The Role of Physical Exercise. | Cells | 2025 | 40862708 | PubTator, text mining | PubMed |
| Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan. | Med Sci (Basel) | 2025 | 40843723 | PubTator, text mining | PubMed |
| Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome. | Nat Commun | 2025 | 40817119 | PubTator, text mining | PubMed |
| Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis. | Front Pharmacol | 2025 | 40808692 | PubTator, text mining | PubMed |
| Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy. | Clinics (Sao Paulo) | 2025 | 40743651 | PubTator, text mining | PubMed |
| The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review. | J Diabetes | 2025 | 40739991 | PubTator, text mining | PubMed |
| FST Polymorphisms Associate with Musculoskeletal Traits and Modulate Exercise Response Differentially by Sex and Modality in Northern Han Chinese Adults. | Genes (Basel) | 2025 | 40725466 | PubTator, text mining | PubMed |
| Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors. | World J Diabetes | 2025 | 40697592 | PubTator, text mining | PubMed |
| State-of-the-art insights into myokines as biomarkers of sarcopenia: a literature review. | Int J Physiol Pathophysiol Pharmacol | 2025 | 40687683 | PubTator, text mining | PubMed |
| Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary Intervention. | Nutrients | 2025 | 40647228 | PubTator, text mining | PubMed |
| A scoring model integrating CXCL9, GDF15, FGF21, and NfL, predicts long-term mortality in type 2 diabetes: a retrospective study. | Cardiovasc Diabetol | 2025 | 40629349 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals shared deregulated neutrophil responses in COVID-19 and idiopathic pulmonary fibrosis. | Respir Res | 2025 | 40500689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10468/papers?page=5